Keith Westby - 04 Apr 2022 Form 4 Insider Report for IVERIC bio, Inc.

Role: SVP & COO
Signature: /s/ Todd Anderman, as attorney-in-fact for Keith Westby
Issuer symbol: N/A
Transactions as of: 04 Apr 2022
Net transactions value: -$570,154
Form type: 4
Filing time: 06 Apr 2022, 18:13:29 UTC
Previous filing: 18 Mar 2022
Next filing: 20 Apr 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ISEE	Common Stock	Options Exercise	$30,018	+20,702	+19%	$1.45^*	129,830	04 Apr 2022	Direct	F1
transaction	ISEE	Common Stock	Sale	$393,346	-20,702	-16%	$19.00	109,128	04 Apr 2022	Direct	F1, F2
transaction	ISEE	Common Stock	Options Exercise	$13,482	+9,298	+8.5%	$1.45^*	118,426	05 Apr 2022	Direct	F1
transaction	ISEE	Common Stock	Sale	$176,808	-9,298	-7.9%	$19.02	109,128	05 Apr 2022	Direct	F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ISEE	Stock Option (right to buy)	Options Exercise	$30,018	-20,702	-21%	$1.45^*	79,298	04 Apr 2022	Common Stock	20,702	$1.45	Direct	F1, F4
transaction	ISEE	Stock Option (right to buy)	Options Exercise	$13,482	-9,298	-12%	$1.45^*	70,000	05 Apr 2022	Common Stock	9,298	$1.45	Direct	F1, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The exercises and sales reported on this form were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2021.
F2	The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions effected at prices ranging from $19.00 to $19.01 per share on April 4, 2022. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Registrant or a security holder of the Registrant, information regarding the number of shares sold at each price within the range.
F3	The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions effected at prices ranging from $19.00 to $19.11 per share on April 5, 2022. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Registrant or a security holder of the Registrant, information regarding the number of shares sold at each price within the range.
F4	This stock option award was granted on December 12, 2018 and vests with respect to 25% of the shares subject to the option on the first anniversary of the grant date and with respect to the remaining shares in approximately equal monthly installments through the fourth anniversary of the grant date.